{"entity":{"type":"insider","cik":"0002038798","url":"/insider/0002038798","json_url":"/insider/0002038798.json","name":"Sloan Sheldon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":4,"first":"2026-04-03","last":"2026-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Sloan Sheldon","source":"filing","n_filings":4,"first_seen":"2026-04-03","last_seen":"2026-07-02"}],"transactions":[{"id":5864150,"accession":"0001636282-26-000087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001636282-26-000087","line_url":"/filing/0001636282-26-000087","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0002038798","owner_name":"Sloan Sheldon","owner_display_name":"Sloan Sheldon","owner_url":"/insider/0002038798","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":87.70045116390689,"price_display":"87.70","price_state":"stated","total_value":730895.56,"total_display":"730,895.56","total_whole":"730,896","shares_owned_after":1834.0,"shares_owned_after_display":"1,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":2},{"id":6197631,"accession":"0001636282-26-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001636282-26-000078","line_url":"/filing/0001636282-26-000078#line-2","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0002038798","owner_name":"Sloan Sheldon","owner_display_name":"Sloan Sheldon","owner_url":"/insider/0002038798","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":624975.0,"total_display":"624,975.00","total_whole":"624,975","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-03","scope":"insider"},{"id":5878005,"accession":"0002038798-26-000004","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0002038798-26-000004","line_url":"/filing/0002038798-26-000004","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0002038798","owner_name":"Sloan Sheldon","owner_display_name":"Sloan Sheldon","owner_url":"/insider/0002038798","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78333.0,"shares_display":"78,333","price_per_share":71.49861693028481,"price_display":"71.50","price_state":"stated","total_value":5600701.16,"total_display":"5,600,701.16","total_whole":"5,600,701","shares_owned_after":57027.0,"shares_owned_after_display":"57,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider","n_lines":7},{"id":5922326,"accession":"0001636282-26-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001636282-26-000030","line_url":"/filing/0001636282-26-000030#line-2","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0002038798","owner_name":"Sloan Sheldon","owner_display_name":"Sloan Sheldon","owner_url":"/insider/0002038798","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7958.0,"shares_display":"7,958","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":397900.0,"total_display":"397,900.00","total_whole":"397,900","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001636282","name":"Spyre Therapeutics, Inc.","url":"/issuer/0001636282","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2026-04-03","last_seen":"2026-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002038798","retrieved_at":"2026-08-26T10:52:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}